Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports.

Conclusion: These two cases suggest that tocilizumab may preserve renal function in the setting of end-stage kidney disease and shift the point of no return for RA patients with AA amyloidosis and renal dysfunction. PMID: 33155543 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33155543?dopt=Abstract

Source: Clinical Nephrology - November 6, 2020 Category: Urology & Nephrology Authors: Fukuda M, Sawa N, Hoshino J, Ohashi K, Motoaki M, Ubara Y Tags: Clin Nephrol Source Type: research